Statement Of Unitholders' Equity

Modalis Therapeutics Corporation - Filing #7272022

Concept As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
As at
2024-12-31
As at
2024-12-31
As at
2024-12-31
2024-01-01 to
2024-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
As at
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2023-12-31
2023-01-01 to
2023-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
As at
2022-12-31
Statement of unitholders' equity
Statement of unitholders' equity
Net assets
21,748,000 JPY
21,748,000 JPY
-97,000 JPY
-97,000 JPY
3,080,722,000 JPY
2,513,987,000 JPY
1,758,987,000 JPY
3,080,722,000 JPY
12,337,000 JPY
3,548,078,000 JPY
566,735,000 JPY
-1,441,083,000 JPY
3,398,529,000 JPY
-1,325,620,000 JPY
-1,441,083,000 JPY
3,420,278,000 JPY
1,758,987,000 JPY
3,513,992,000 JPY
12,337,000 JPY
26,430,000 JPY
26,430,000 JPY
1,217,652,000 JPY
-2,410,273,000 JPY
-2,402,547,000 JPY
1,354,394,000 JPY
1,972,652,000 JPY
2,539,387,000 JPY
-97,000 JPY
-2,402,547,000 JPY
-97,000 JPY
7,323,000 JPY
1,380,422,000 JPY
566,735,000 JPY
1,217,652,000 JPY
1,346,669,000 JPY
7,323,000 JPY
2,539,387,000 JPY
1,380,824,000 JPY
18,923,000 JPY
16,483,000 JPY
-97,000 JPY
16,483,000 JPY
2,941,232,000 JPY
-2,586,894,000 JPY
-97,000 JPY
2,094,767,000 JPY
2,094,767,000 JPY
-2,586,894,000 JPY
566,735,000 JPY
2,905,825,000 JPY
2,943,201,000 JPY
3,416,502,000 JPY
2,849,767,000 JPY
3,416,502,000 JPY
2,924,277,000 JPY
-2,605,346,000 JPY
18,923,000 JPY
Changes during period
Net changes in items other than shareholders' equity
-4,681,000 JPY
JPY
JPY
5,013,000 JPY
-4,681,000 JPY
332,000 JPY
JPY
5,013,000 JPY
JPY
-4,681,000 JPY
7,506,000 JPY
7,506,000 JPY
-9,160,000 JPY
-1,653,000 JPY
-9,160,000 JPY
JPY
JPY
JPY
JPY
7,506,000 JPY
Total changes during period
-4,681,000 JPY
541,335,000 JPY
2,044,135,000 JPY
541,335,000 JPY
5,013,000 JPY
JPY
JPY
JPY
2,039,453,000 JPY
2,167,655,000 JPY
2,167,323,000 JPY
541,335,000 JPY
5,013,000 JPY
541,335,000 JPY
1,084,653,000 JPY
961,464,000 JPY
961,464,000 JPY
541,335,000 JPY
-4,681,000 JPY
7,506,000 JPY
7,506,000 JPY
-9,160,000 JPY
-1,560,810,000 JPY
JPY
184,346,000 JPY
JPY
-9,160,000 JPY
-1,559,156,000 JPY
-877,114,000 JPY
-877,114,000 JPY
184,346,000 JPY
-877,114,000 JPY
195,073,000 JPY
-1,569,883,000 JPY
-877,114,000 JPY
-1,562,376,000 JPY
JPY
-877,114,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.